Conventional NSAA clinical trials

Enzalutamide in Androgen Deprivation Therapy With Radiation Therapy for High Risk, Clinically Localised, Prostate Cancer

This study looks at a medicine called enzalutamide for men with prostate cancer that hasn't spread but is high-risk. It aims to see if adding enzalutamide to standard hormone therapy and radiation helps prevent the cancer from coming back.